- ByInvesting.com-
Investing.com -- Belgian healthcare real estate company Aedifica has received regulatory approval for its acquisition of...
Last | High | Low | |||||
|---|---|---|---|---|---|---|---|
| 240.00 | 241.40 | 238.00 | +4.20 | +1.78% | 22.41K | ||
| 87.45 | 89.00 | 87.20 | +1.40 | +1.63% | 96.24K | ||
| 116.90 | 117.15 | 115.85 | +1.85 | +1.61% | 454.91K | ||
| 25.76 | 26.04 | 25.32 | +0.54 | +2.14% | 553.09K | ||
| 80.35 | 80.70 | 80.00 | +1.30 | +1.64% | 79.1K | ||
| 258.90 | 260.40 | 252.50 | +6.00 | +2.37% | 172.48K | ||
| 59.32 | 59.50 | 58.80 | +0.64 | +1.09% | 947.38K | ||
| 59.00 | 59.65 | 58.90 | +0.20 | +0.34% | 237.75K | ||
| 20.36 | 20.84 | 20.02 | +0.66 | +3.35% | 1.19M | ||
| 74.00 | 75.40 | 73.70 | +0.80 | +1.09% | 199.26K | ||
| 112.70 | 114.30 | 110.90 | +0.40 | +0.36% | 263.26K | ||
| 9,360.0 | 9,380.0 | 9,110.0 | +390.0 | +4.35% | 839 | ||
| 64.85 | 65.80 | 64.55 | +1.15 | +1.81% | 32.26K | ||
| 72.00 | 72.30 | 71.20 | +1.50 | +2.13% | 37.95K | ||
| 245.60 | 250.20 | 245.00 | +2.20 | +0.90% | 23.24K | ||
| 22.70 | 22.82 | 22.42 | +0.56 | +2.53% | 397.98K | ||
| 186.40 | 189.30 | 186.40 | -0.20 | -0.11% | 58.79K | ||
| 699.00 | 703.80 | 693.00 | +3.00 | +0.43% | 90.74K | ||
| 8.41 | 8.47 | 8.23 | +0.10 | +1.20% | 552.05K | ||
| 73.32 | 74.60 | 73.16 | +0.34 | +0.47% | 131.66K |
Investing.com -- Belgian healthcare real estate company Aedifica has received regulatory approval for its acquisition of...
Investing.com -- Sofina reported a 1% increase in net asset value (NAV) per share for the second half of 2025, rising from €296 to...
Investing.com -- Jefferies upgraded D’Ieteren Group to “buy” from “hold” rating and lifted its price...
Upcoming U.S. retail sales data is expected to influence market perceptions, building on a recent increase. Companies like Target...
After the Iran-Israel situation fizzled out for the time being, the Cboe Volatility Index (VIX) dropped from its yearly high of...
Dividend stocks can provide regular income and outperform the broader market. When building a dividend portfolio, investors should...
No Earning Reports have been scheduled